160 related articles for article (PubMed ID: 21292563)
1. An injectable method for noninvasive spine fusion.
Olabisi RM; Lazard Z; Heggeness MH; Moran KM; Hipp JA; Dewan AK; Davis AR; West JL; Olmsted-Davis EA
Spine J; 2011 Jun; 11(6):545-56. PubMed ID: 21292563
[TBL] [Abstract][Full Text] [Related]
2. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
[TBL] [Abstract][Full Text] [Related]
3. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy.
Alden TD; Pittman DD; Beres EJ; Hankins GR; Kallmes DF; Wisotsky BM; Kerns KM; Helm GA
J Neurosurg; 1999 Jan; 90(1 Suppl):109-14. PubMed ID: 10413134
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
6. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique.
Riew KD; Lou J; Wright NM; Cheng SL; Bae KT; Avioli LV
J Bone Joint Surg Am; 2003 May; 85(5):866-71. PubMed ID: 12728037
[TBL] [Abstract][Full Text] [Related]
7. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.
Kim HS; Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Minamide A; Suh DY; Titus L
Spine (Phila Pa 1976); 2003 Feb; 28(3):219-26. PubMed ID: 12567021
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
Park SB; Park SH; Kim NH; Chung CK
Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
[TBL] [Abstract][Full Text] [Related]
11. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
[TBL] [Abstract][Full Text] [Related]
12. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent.
Helm GA; Alden TD; Beres EJ; Hudson SB; Das S; Engh JA; Pittman DD; Kerns KM; Kallmes DF
J Neurosurg; 2000 Apr; 92(2 Suppl):191-6. PubMed ID: 10763690
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model.
Kaito T; Johnson J; Ellerman J; Tian H; Aydogan M; Chatsrinopkun M; Ngo S; Choi C; Wang JC
J Bone Joint Surg Am; 2013 Sep; 95(17):1612-9. PubMed ID: 24005203
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.
Douglas JT; Rivera AA; Lyons GR; Lott PF; Wang D; Zayzafoon M; Siegal GP; Cao X; Theiss SM
J Spinal Disord Tech; 2010 Feb; 23(1):63-73. PubMed ID: 20084034
[TBL] [Abstract][Full Text] [Related]
15. Lumbar spine intervertebral disc gene delivery of BMPs induces anterior spine fusion in lewis rats.
Cunningham ME; Kelly NH; Rawlins BA; Boachie-Adjei O; van der Meulen MCH; Hidaka C
Sci Rep; 2022 Oct; 12(1):16847. PubMed ID: 36207369
[TBL] [Abstract][Full Text] [Related]
16. Development of a Cell-Based Gene Therapy Approach to Selectively Turn Off Bone Formation.
Alvarez-Urena P; Zhu B; Henslee G; Sonnet C; Davis E; Sevick-Muraca E; Davis A; Olmsted-Davis E
J Cell Biochem; 2017 Nov; 118(11):3627-3634. PubMed ID: 28621436
[TBL] [Abstract][Full Text] [Related]
17. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
[TBL] [Abstract][Full Text] [Related]
18. Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose.
Pelletier MH; Oliver RA; Christou C; Yu Y; Bertollo N; Irie H; Walsh WR
Spine J; 2014 Aug; 14(8):1758-68. PubMed ID: 24486479
[TBL] [Abstract][Full Text] [Related]
19. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
